Collage photo of Yelak Biru and Rahul Banerjee
Apr 19, 2025, 19:17
Yelak Biru: Rahul Banerjee on redefining ‘cure’ in myeloma
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, shared a post on X:
“Part of the problem is how one even defines ‘cure,’ said Rahul Banerjee, who now oversees Crow’s care.
‘We sometimes talk about a ‘functional cure’ or ‘operative cure’ whereby most patients live as long as they would otherwise while simultaneously remaining vigilant for the risk of myeloma coming back. You’re still under surveillance, but when you die, you’re not dying with myeloma or from a side effect.
I would call that ‘cure.’ But if ‘cure’ means being able to walk away from ever having to see an oncologist or check myeloma labs again, then we’re really not there in myeloma.’ “
More posts featuring Yelak Biru.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53
Apr 19, 2025, 17:17